Episode Details
Back to Episodes
Episode: 66 - John Lambert on Antibody Drug Conjugates Then, Now, & Beyond
Season 3
Episode 66
Published 1 year, 10 months ago
Description
October 15, 2024 | In this month’s episode of The Chain, host Rakesh Dixit, PhD, DABT, president and founder of Bionavigen Oncology and Regio Biosciences, and John Lambert, PhD, consultant, about antibody drug conjugates (ADCs) then, now, and beyond. Lambert shares his experiences from his decades-long career at ImmunoGen, why ADCs are more successful now compared to in the past, and where he sees ADCs going forward. He also discusses his thoughts on the half-life of diffusible payloads, the toxicity of the bystander effect, and more.
LINKS:
Bionavigen
ImmunoGen